Ignite Creation Date:
2024-05-05 @ 7:52 PM
Last Modification Date:
2024-10-26 @ 9:55 AM
Study NCT ID:
NCT00757341
Status:
COMPLETED
Last Update Posted:
2009-04-27
First Post:
2008-09-19
Brief Title:
Study Evaluating The Mass Balance And Metabolic Disposition Of SKI-606
Sponsor:
Wyeth is now a wholly owned subsidiary of Pfizer
Organization:
Wyeth is now a wholly owned subsidiary of Pfizer
Study Overview
Official Title:
An Open-Label Single-Dose Study of the Mass Balance and Metabolic Disposition of Orally Administered 14C-Labeled Bosutinib in Healthy Male Subjects
Status:
COMPLETED
Status Verified Date:
2009-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study will assess the mass balance metabolic disposition and identification of metabolites following single oral administration of 14C-SKI-606 in healthy male subjects
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None